ITMO public health
Last update : 09/05/2017 | Version : 3 | ID : 6396
| General | |
| Identification | |
| Detailed name | Assessment of lipid-lowering treatment in France |
| Sign or acronym | CEPHEUS |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL méthodologie de référence MR-001; Avis favorable n° 2-06-14/Avis n°2 du CCPPRB Toulouse II du 5 mai 2006; Avis favorable AFSSAPS n°060544 du 25 août 2006 |
| General Aspects | |
| Medical area |
Cardiology Hematology |
| Keywords | Guidelines, LDL cholesterol, Lipid-lowering drugs, Statins, France |
| Scientific investigator(s) (Contact) | |
| Name of the director | Ferrières |
| Surname | Jean |
| Address | Faculté de médecine 37 allée Jules Guesde 31073 Toulouse Cedex |
| Phone | +33 (0)5 61 14 59 49 |
| jean.ferrieres@univ-toulouse.fr | |
| Unit | Département d'épidémiologie INSERM UMR1027 |
| Organization | CHU de |
| Collaborations | |
| Funding | |
| Funding status |
Private |
| Details | Astra Zeneca (laboratoire pharmaceutique) |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | CHU de toulouse |
| Organisation status |
Public |
| Sponsor(s) or organisation(s) responsible | Promoteur : Astra Zeneca SAS 92844 Rueil Malmaison |
| Organisation status |
Private |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
| Database recruitment is is made on the basis of: |
Medication(s) taken |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | All included patients visiting a general practitioner for any reason and corresponding to the criteria are invited to participate. |
| Database objective | |
| Main objective | Determine the proportion of patients on lipid-lowering drugs who reach the LDL-C goals recommended in guidelines. |
| Inclusion criteria | man or woman - adult - treated with lipid-lowering drugs for at least three months, with no dose adjustment for a minimum of six weeks |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) |
| Population covered |
Sick population |
| Gender |
Male Woman |
| Geography area |
International |
| Detail of the geography area | 8 european countries: Belgium, France, Greece, Ireland, Netherlands, Finland, Turkey and Luxembourg |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 05/2006 |
| Date of last collection (YYYY or MM/YYYY) | 12/2006 |
| Size of the database | |
| Size of the database (number of individuals) |
[1000-10 000[ individuals |
| Details of the number of individuals | 1966 french subjects |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Clinical data Declarative data Biological data |
| Clinical data (detail) |
Medical registration |
| Declarative data (detail) |
Paper self-questionnaire |
| Biological data (detail) | fasting blood sample |
| Presence of a biobank |
No |
| Health parameters studied |
Health event/morbidity Health care consumption and services |
| Care consumption (detail) |
Hospitalization Medical/paramedical consultation Medicines consumption |
| Procedures | |
| Participant monitoring |
No |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Link to the document | http://www.sciencedirect.com/science/article/pii/S1875213608001150 |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | Contact scientific investigator. |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
| ABOUT | CATALOG | RESOURCES | USEFUL LINKS |
This site complies with the HONcode standard for trustworthy health information: |
8 rue de la Croix Jarry 75013 Paris Phone : +33 1 44 23 67 47 |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05
